Literature DB >> 5414296

Succinylcholine--danger in the spinal-cord-injured patient.

W A Stone, T P Beach, W Hamelberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5414296     DOI: 10.1097/00000542-197002000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  16 in total

1.  Suxamethonium is contraindicated in the Guillain-Barré syndrome.

Authors:  M Reilly; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

2.  Changes in plasma potassium and calcium levels and in the electrocardiogram after a single dose of succinylcholine preceded by d-tubocurarine.

Authors:  W Evers; G B Racz; A A Levy
Journal:  Can Anaesth Soc J       Date:  1976-07

3.  Early management of spinal cord injury.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

4.  [Post-succinylcholine hyperkalemia].

Authors:  H Desmeules
Journal:  Can Med Assoc J       Date:  1973-06-23       Impact factor: 8.262

5.  The effects of precurarization with a protective dose of d-tubocurarine in the conscious patient.

Authors:  R Déry
Journal:  Can Anaesth Soc J       Date:  1974-01

Review 6.  Hyperkalaemia following succinylcholine administration in neurological disorders: a review.

Authors:  R B Smith
Journal:  Can Anaesth Soc J       Date:  1971-03

7.  Succinylcholine induced hyperkalaemia in patients with strabismus.

Authors:  P E Berkebile; H H Pfaeffle; R B Smith
Journal:  Can Anaesth Soc J       Date:  1973-03

8.  The heart in the Guillain-Barré syndrome.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

Review 9.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 10.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.